Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:959925rdf:typepubmed:Citationlld:pubmed
pubmed-article:959925lifeskim:mentionsumls-concept:C0041296lld:lifeskim
pubmed-article:959925lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:959925lifeskim:mentionsumls-concept:C0005680lld:lifeskim
pubmed-article:959925lifeskim:mentionsumls-concept:C0238605lld:lifeskim
pubmed-article:959925lifeskim:mentionsumls-concept:C0022209lld:lifeskim
pubmed-article:959925lifeskim:mentionsumls-concept:C0449438lld:lifeskim
pubmed-article:959925pubmed:issue29lld:pubmed
pubmed-article:959925pubmed:dateCreated1976-10-29lld:pubmed
pubmed-article:959925pubmed:abstractTextBlack male tuberculosis patients (106) were phenotyped into 59% fast and 41% slow acetylators with isoniazid (NH) plasma half-lives. The antimode time dividing the two acetylator groups was longer than that previously reported for Whites. The therapeutic significance of INH acetylator phenotyping per se is questioned since it provides neither a measurement of the amount of INH absorption nor of its distribution within the body.lld:pubmed
pubmed-article:959925pubmed:languageenglld:pubmed
pubmed-article:959925pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:959925pubmed:citationSubsetIMlld:pubmed
pubmed-article:959925pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:959925pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:959925pubmed:statusMEDLINElld:pubmed
pubmed-article:959925pubmed:monthJullld:pubmed
pubmed-article:959925pubmed:issn0256-9574lld:pubmed
pubmed-article:959925pubmed:authorpubmed-author:LearyW PWPlld:pubmed
pubmed-article:959925pubmed:authorpubmed-author:BachP HPHlld:pubmed
pubmed-article:959925pubmed:authorpubmed-author:Higgins-Opitz...lld:pubmed
pubmed-article:959925pubmed:authorpubmed-author:BoleC TCT2ndlld:pubmed
pubmed-article:959925pubmed:issnTypePrintlld:pubmed
pubmed-article:959925pubmed:day10lld:pubmed
pubmed-article:959925pubmed:volume50lld:pubmed
pubmed-article:959925pubmed:ownerNLMlld:pubmed
pubmed-article:959925pubmed:authorsCompleteYlld:pubmed
pubmed-article:959925pubmed:pagination1132-4lld:pubmed
pubmed-article:959925pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:959925pubmed:meshHeadingpubmed-meshheading:959925-H...lld:pubmed
pubmed-article:959925pubmed:meshHeadingpubmed-meshheading:959925-A...lld:pubmed
pubmed-article:959925pubmed:meshHeadingpubmed-meshheading:959925-T...lld:pubmed
pubmed-article:959925pubmed:meshHeadingpubmed-meshheading:959925-A...lld:pubmed
pubmed-article:959925pubmed:meshHeadingpubmed-meshheading:959925-A...lld:pubmed
pubmed-article:959925pubmed:meshHeadingpubmed-meshheading:959925-M...lld:pubmed
pubmed-article:959925pubmed:meshHeadingpubmed-meshheading:959925-A...lld:pubmed
pubmed-article:959925pubmed:meshHeadingpubmed-meshheading:959925-S...lld:pubmed
pubmed-article:959925pubmed:meshHeadingpubmed-meshheading:959925-A...lld:pubmed
pubmed-article:959925pubmed:meshHeadingpubmed-meshheading:959925-I...lld:pubmed
pubmed-article:959925pubmed:meshHeadingpubmed-meshheading:959925-M...lld:pubmed
pubmed-article:959925pubmed:meshHeadingpubmed-meshheading:959925-P...lld:pubmed
pubmed-article:959925pubmed:meshHeadingpubmed-meshheading:959925-H...lld:pubmed
pubmed-article:959925pubmed:meshHeadingpubmed-meshheading:959925-A...lld:pubmed
pubmed-article:959925pubmed:year1976lld:pubmed
pubmed-article:959925pubmed:articleTitleIsoniazid acetylator status of Black South African tuberculosis patients.lld:pubmed
pubmed-article:959925pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:959925lld:pubmed